Dr. Valantine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-497-8000- Is this information wrong?
Education & Training
St. George's Hospital Medical SchoolClass of 1978
Certifications & Licensure
CA State Medical License 1988 - 2026
Clinical Trials
- IMAGE: A Comparison of AlloMap Molecular Testing and Traditional Biopsy-based Surveillance for Heart Transplant Rejection Start of enrollment: 2005 Jan 01
- Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation Start of enrollment: 2010 Jul 01
- Heartsbreath Test for Heart Transplant Rejection Start of enrollment: 2010 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Sex-specific patterns of donor-derived cell-free DNA in heart transplant rejection: An analysis from the Genomic Research Alliance for Transplantation (GRAfT).Ersilia M DeFilippis, Benjamin Sweigart, Kiran K Khush, Palak Shah, Sean Agbor-Enoh, Hannah A Valantine, Amanda R Vest> ;The Journal of Heart and Lung Transplantation. 2024 Mar 7
- Neural responses to gender-based microaggressions in academic medicine.Stephanie Balters, Lara C Foland-Ross, Jennifer Bruno, Vyjeyanthi S Periyakoil, Hannah Valantine, Allan L Reiss> ;Journal of Neuroscience Research. 2023 Dec 1
- 1 citationsThe Time to Act Is Now: Racial Disparities After Heart Transplantation.Kiran K Khush, Hannah A Valantine> ;Circulation. 2023 Jul 18
- Join now to see all
Journal Articles
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationKiran Khush, Alan C Yeung, Hannah Valantine, William F Fearon, Journal of Cardiac Failure
Other
- Induction and maintenance of immunosuppressive therapy in cardiac transplantationValantine HA, Pham MX
http://www.uptodate.com/contents/induction-and-maintenance-of-immunosuppressive-therapy-in-cardiac-t
UpToDate, Wolters Kluwer Health - 2012-04-06
Authored Content
- Association of Endothelin-1 with Accelerated Cardiac Allograft Vasculopathy and Late Mortality Following Heart TransplantationDecember 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Long-Term Prognostic Value of Invasive and Non-Invasive Measures Early After Heart TransplantationApril 2018
- Join now to see all
Press Mentions
Stanford Researchers Testing Ways to Improve Clinical Trial DiversityJune 22nd, 2022- CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement AwardApril 28th, 2022
- CareDx Congratulates Board Member Dr. Hannah Valantine on ISHLT Lifetime Achievement AwardApril 28th, 2022
- Join now to see all
Grant Support
- Eradicating Stereotype Threat: Intervening To Retain And Advance Women FacultyNational Institute Of General Medical Sciences2010
- Genome Transplant Dynamics: Non-Invasive Sequencing-Based Diagnosis Of RejectionNational Institute Of Allergy And Infectious Diseases2010
- Transplant Arteriosclerosis: Viral And Host MechanismsNational Center For Research Resources2004–2007
- Host-Viral Immune Responses--Transplant ArteriosclerosisNational Institute Of Allergy And Infectious Diseases2001–2002
- Core--Clinical Research FacilityNational Institute Of Allergy And Infectious Diseases2001–2002
- Optimization Of Rodent Models Of Transplant CADNational Heart, Lung, And Blood Institute1999
- Immune Mediators Of Acute Cardiac Allograft DysfunctionNational Heart, Lung, And Blood Institute1991–1995
Other Languages
- French
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
